worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Novartis Investor Relations

Novartis Investor Relations

Sales and results 

View quarterly results, Annual Reports and our Form 20-F.

Share data and analysis 

Learn more about the history and performance of Novartis shares on the NYSE and SWX, ownership details and dividend history.

 
 

NOVZn

 

 

 
 

NVS

 

 

Fixed-income securities 

Learn more about the fixed-income securities issued by Novartis.

Presentations and Events 

Find out about upcoming events for shareholders.

Shareholders' corner 

Learn more about our Direct Share Purchase Plan, our Direct American Depositary Share Purchase Plan and other information specific to private investors (including information in Japanese).

Corporate governance 

Novartis is committed to good corporate governance. Read the Articles of Incorporation, the Regulations of the Board and the Charters of the Board Committees for more information.

Investor relations contacts 

Our team of experts looks forward to helping you.

 

The 46 projects submitted in 2008 to the Novartis Energy Excellence Awards have led to cost savings of USD 17 million, representing 5% of our total energy costs.

During 2008, Novartis increased research and development investments by 12% to USD 7.2 billion. This is one of the highest figures in the industry relative to sales (17.4%).

SWX

NYSE

 
 

NOVZn

 
 

NVS

Clinical pipeline

Clinical pipeline

Our product pipeline has 149 projects in various stages of clinical development.

Latest news

Corporate publications

Corporate publications

Download our latest financial reports.